SKAN Group AG Announces CEO Transition
On September 1, 2025, SKAN Group AG, a leading health care supplier based in Switzerland, announced a significant leadership change. Jonas Greutert is set to take over as CEO from Thomas Huber, effective January 1, 2026. This transition marks the culmination of the company’s strategic succession planning, as confirmed by the Board of Directors.
Leadership Transition
Thomas Huber, who has been at the helm for the past eight years, is credited with steering SKAN Group to new heights. Under his leadership, the company has become a global market leader in high-quality isolator systems for aseptic production processes in the pharmaceutical and biotechnology industries. The company has experienced substantial revenue growth, expanded its international presence, and fortified its high-margin Services & Consumables segment.
Beat Lüthi, Chairman of the Board of SKAN Group, expressed gratitude towards Thomas Huber for his exceptional leadership. “On behalf of the Board and all employees, I extend our sincere gratitude to Thomas Huber for his outstanding leadership,” Lüthi stated. The Board is confident that Jonas Greutert will continue to drive the company’s growth and maintain its position as a leader in the health care sector.
Company Overview
SKAN Group AG operates in the health care sector, specifically within the capital markets industry. The company is listed on the SIX Swiss Exchange and trades in Swiss Francs (CHF). As of August 28, 2025, SKAN Group’s close price was 61.4 CHF, with a 52-week high of 82 CHF on September 16, 2024, and a 52-week low of 56 CHF on April 6, 2025. The company boasts a market capitalization of 1.4 billion CHF and a price-to-earnings ratio of 86.59.
SKAN Group specializes in providing isolators, cleanroom devices, and decontamination processes essential for the aseptic production of biopharmaceutical products. Their operations primarily serve customers based in Switzerland, and more information about their offerings can be found on their website at www.skan.com .
The leadership transition is expected to ensure the continued success and sustainability of SKAN Group’s growth trajectory, as the company remains committed to innovation and excellence in the health care industry.